Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Features

Top News in Endovascular Therapy: 2018

L.A. McKeown

December 28, 2018

News Daily News

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

L.A. McKeown

December 18, 2018

News Daily News

NOACs Significantly Curb Risk of VTE in Cancer Patients

L.A. McKeown

December 06, 2018

News Daily News

FDA Warns of Stroke and Arterial Dissection Risk With MS Drug

L.A. McKeown

November 29, 2018

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

L.A. McKeown

November 15, 2018

News Daily News

Study Questions Role of BP Meds in Patients With Hypertension but No Other CVD Risk Factors

L.A. McKeown

October 30, 2018

News Daily News

More Research Supports Use of Aspirin Alone to Prevent VTE After Knee Replacement Surgery

L.A. McKeown

October 18, 2018

News Daily News

CAC Scoring Is Predictive of Risk Across Races and Ethnicities

L.A. McKeown

October 16, 2018

News Daily News

Bleeding Risk Increased With NSAID Use in Anticoagulated A-fib Patients: RE-LY Analysis

L.A. McKeown

July 10, 2018

News Daily News

Real-world Analysis Suggests Apixaban Is Safest of the NOACs, Even for Patients With A-fib

L.A. McKeown

July 06, 2018

News Daily News

Lower BP Targets Can Save Over 300,000 Lives a Year, Analysis Suggests

L.A. McKeown

May 23, 2018

News Daily News

NAVIGATE ESUS: Rivaroxaban Fails to Prevent More Recurrent Cryptogenic Strokes Than Aspirin

L.A. McKeown

May 16, 2018

News Daily News

Spin to Win: Results From Late-Breaking Meeting Trials Often Overstated

L.A. McKeown

May 15, 2018

News Conference News SCAI 2018

Coronary Plaques in Psoriasis Patients Change After Treatment With Biologics

L.A. McKeown

May 01, 2018

News Features

Mercury Rising: As Doctors’ Groups Face Off Over BP Guidelines, Will Patients Fall Through the Cracks?

L.A. McKeown

February 26, 2018

News Daily News

Synopsis of New Hypertension Guidelines Renews Concerns and Controversy

L.A. McKeown

January 22, 2018

News Daily News

NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin

L.A. McKeown

January 02, 2018

Advertisement

Top News in Endovascular Therapy: 2018

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

NOACs Significantly Curb Risk of VTE in Cancer Patients

FDA Warns of Stroke and Arterial Dissection Risk With MS Drug

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

Study Questions Role of BP Meds in Patients With Hypertension but No Other CVD Risk Factors

More Research Supports Use of Aspirin Alone to Prevent VTE After Knee Replacement Surgery

CAC Scoring Is Predictive of Risk Across Races and Ethnicities

Bleeding Risk Increased With NSAID Use in Anticoagulated A-fib Patients: RE-LY Analysis

Real-world Analysis Suggests Apixaban Is Safest of the NOACs, Even for Patients With A-fib

Lower BP Targets Can Save Over 300,000 Lives a Year, Analysis Suggests

NAVIGATE ESUS: Rivaroxaban Fails to Prevent More Recurrent Cryptogenic Strokes Than Aspirin

Spin to Win: Results From Late-Breaking Meeting Trials Often Overstated

Coronary Plaques in Psoriasis Patients Change After Treatment With Biologics

Mercury Rising: As Doctors’ Groups Face Off Over BP Guidelines, Will Patients Fall Through the Cracks?

Synopsis of New Hypertension Guidelines Renews Concerns and Controversy

NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content